Volgende

Automatisch afspelen

Dr. Ai on Potential With Mogamulizumab in CTCL

3 Bekeken • 08/09/23
Delen
insluiten
administrator
administrator
abonnees
0

Weiyun Z. Ai, MD, PhD, assistant clinical professor, Department of Medicine, University of California San Francisco, speaks to the relevance of mogamulizumab (Poteligeo) in treating Sezary syndrome, a rare and aggressive form of cutaneous T-cell lymphoma

Laat meer zien
0 Comments sort Sorteer op
Facebook Reacties

Volgende

Automatisch afspelen